• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

dkNET community events and announcements in April, 2020

Dear dkNET Community,

dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.


dkNET News

Funding opportunity

  • 2020 dkNET Summer of Data Student Internship To support researchers with the use of on-line resources, the 6-week dkNET Summer of Data Student Internship program provides students an opportunity to utilize the dkNET tools and resources in a research project and to provide feedback on their experience to the dkNET team. Students will learn best practices to enhance rigor and reproducibility and learn the basics of good data management by following the FAIR (Findable, Accessible, Interoperable, Reusable) data principles. dkNET will award a $1,000 scholarship to a limited number of high school, undergraduate or graduate (Masters or PhD) students who are working in a research lab during summer 2020. Awards will be determined by a competitive selection process. Application due date: April 17, 2020.

dkNET webinar


Events in April, 2020

Apr. 3, 2020

American Diabetes Association COVID-19 Webinar Series: COVID-19 and Diabetes - Current and Future Impact

Synopsis of the Epidemiology: Coronavirus infection in people with diabetes; Outcomes in people with diabetes

Management of Diabetes in the Time of COVID-19: Switching to telemedicine; What can and can’t you do?

What is the path forward after the pandemic? Will diabetes care/management ever be the same?

Panelists: Carlos del Rio, MD,  Guillermo Umpierrez, MDMohammed K. Ali, MD, MSc, MBA

More information: https://zoom.us/j/943721209


Apr. 03-07, 2020

Keystone Symposia: Integrating Metabolism and Immunity [Cancelled]

Location:  Keystone, CO 80435, USA

More information: http://www.keystonesymposia.org/20D2 Apr. 04-07, 2020

Experimental Biology 2020 *Meet the dkNET Team [Cancelled]

Experimental Biology (EB) is the annual meeting of five societies bringing together more than 12,000 scientists and 25 guest societies in one interdisciplinary community. EB 2020 will be held from April 4–7, 2020, at the San Diego Convention Center in San Diego, California. EB is the place to explore the latest cutting edge science in anatomy, biochemistry and molecular biology, investigative pathology, pharmacology and physiology. EB welcomes everyone with interest in advancing the latest research impacting life sciences. Attendees represent scientists from academic institutions, government agencies, non-profit organizations and industry. This multidisciplinary, scientific meeting features plenary lectures, workshops, symposia, posters presentations, on-site career services and exhibits spotlighting products and services integral to this professional community.

Location:  San Diego, CA, USA

More information: https://experimentalbiology.org/2020/home.aspx


Apr. 24, 2020

dkNET Webinar: Addgene


Funding opportunities information and deadlines in April, 2020

*Please note that due to COVID-19 pandemic situation, NIH grant applications submitted late for due dates between march 9, 2020 and May 1, 2020 will be accepted through May 1, 2020 [NOT-OD-20-091]. For more information, please check NIH Coronavirus Disease 2019 (COVID-10) Information for NIH Applicants and Recipients

Apr. 01, 2020

NIDDK Funding Opportunity Application Due Date: Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) requests applications to explore human pancreatic tissues for the discovery of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the discovery of early biomarkers of T1D pathogenesis, the development of diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification and biological validation of therapeutic targets for the development of preventative or early treatment strategies. Successful applicants will join the Consortium on Beta Cell Death and Survival (CBDS), whose mission is to better define and detect the mechanisms of beta cell stress and destruction central to the development of T1D in humans, with­ the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and of preventing the progression to autoimmunity. The CBDS is part of a collaborative research framework, the Human Islet Research Network(HIRN, https://hirnetwork.org/), whose overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This FOA will only support studies with a primary focus on increasing our understanding of human disease biology (as opposed to rodent or other animal models). This FOA will not accept applications proposing a clinical trial.

More information:  https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-024.html


Apr. 07, 2020

NIDDK Funding Opportunity Application Due Date: Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective open- and closed-loop glucose control systems. Proposed research should tackle important obstacles at the level of sensing, hormone formulation and delivery, self-management decision support systems, and/or design of automated controllers/algorithms able to manage an integrated platform. This research may contribute to development of affordable and user friendly technologies to improve glucose control in patients with type 1 diabetes.

More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-029.html

Apr. 09, 2020

NIDDK Funding Opportunity Application Due Date: Clinical Trials to Test Artificial Pancreas Device Systems in Populations Challenging to Manage Type 1 Diabetes (T1D) (U01 Clinical Trial Required)

This FOA will support the conduct of clinical trials designed to test the clinical safety and efficacy of artificial pancreas (AP) device systems with the objective of improving glycemic control, reducing acute complications and improving quality of life in people with difficult to control T1D when using standard of care therapies.

More information:  https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-036.html

Apr. 09, 2020

NIDDK Funding Opportunity Application Due Date: Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of new approaches to create devices/components with enhanced accuracy and less patient burden that will represent real advancements regarding safety and effectiveness of glucose control technologies and their integration into open and closed loop hormone replacement systems.

More information:  https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-027.html

Apr. 09, 2020

NIDDK Funding Opportunity Application Due Date: Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of new approaches to create devices/components with enhanced accuracy and less patient burden that will represent real advancements regarding safety and effectiveness of glucose control technologies and their integration into open and closed loop hormone replacement systems.

More information:  https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-027.html

Apr. 09, 2020

NIDDK Funding Opportunity Application Due Date: Support for Small Business Innovation Research (SBIR) to Development and Testing of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment.

More information:  https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-028.html

Apr. 17, 2020

dkNET Funding Opportunity Application Deadline: 2020 dkNET Summer of Data Student Internship

The intent of this program is to enable students, over a 6-week period, to use the dkNET portal to support their own research or that of their PI’s. The intent is they will learn best practices to enhance rigor and reproducibility and learn the basics of good data management by following the FAIR (Findable, Accessible, Interoperable, Reusable) data principles. Preferences will be given to those research projects that would most benefit from the types of services offered by dkNET, e.g., projects that involve antibodies, genetically modified organisms, and ‘omics’ data in the areas of focus for NIDDK including diabetes, obesity, nutrition, digestive, kidney, liver, urologic, endocrine, metabolic, bone, and blood diseases.

More information: https://dknet.org//about/Summer-Internship


Apr. 21, 2020

NIDDK Funding Opportunity Letter of Intent Due Date: New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional)

NIDDK utilizes High Impact, Interdisciplinary Science (RC2) grants to support projects that will lay the foundation for new fields of investigation within the mission of NIDDK. The RC2 is envisioned to use an interdisciplinary approach to generate a research resource and/or foster discovery-based or hypothesis-generating science that can have a significant impact on the broader scientific community. This targeted FOA specifically seeks to generate scientific advancements that are focused on identifying new signals and regulatory networks that mediate metabolic cross talks within and between organs that play a role in the development of diabetes and obesity. The interdisciplinary approaches proposed should be designed to foster novel synergies that will accelerate conceptual and technical breakthroughs in science related to metabolic tissue communication. Letter of Intent due: Six weeks prior to application due date. Application due date: June 2, 2020.

More information:  https://grants.nih.gov/grants/guide/pa-files/PAR-18-886.html

Apr. 22, 2020

NIDDK Funding Opportunity Letter of Intent Due Date: Patient-oriented Research to Mitigate Health Disparitiesand Lessen the Burden of Chronic Diseases Within the Mission of NIDDK (R01 Clinical Trial Optional)

This Funding Opportunity Announcement invites applications to conduct patient-oriented clinical research studies designed to develop strategies to mitigate health disparities in people with one or more chronic diseases or conditions within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Populations of interest include those disproportionately burdened with multiple chronic conditions and/or disparities in social, behavioral and/or biological risk factors. Only studies that involve interaction with human participants will be considered appropriate for this FOA.

More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-015.html


X

Are you sure you want to delete that component?